Gilead Trodelvy with Merck’s Keytruda controls lung cancer
Justin Sullivan/Getty Images News Gilead (NASDAQ:GILD) announced Sunday that its antibody-drug conjugate Trodelvy and Merck’s (NYSE:MRK) anti-PD-1 immunotherapy Keytruda cut ...
Justin Sullivan/Getty Images News Gilead (NASDAQ:GILD) announced Sunday that its antibody-drug conjugate Trodelvy and Merck’s (NYSE:MRK) anti-PD-1 immunotherapy Keytruda cut ...